Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus Interventions: Drug: Dapagliflozin; Drug: Empagliflozin; Drug: Canagliflozin Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2019 Category: Research Source Type: clinical trials
Replication of the CANVAS Diabetes Trial in Healthcare Claims
Condition: Diabetes Interventions: Drug: Canagliflozin; Drug: DPP-4 inhibitor Sponsor: Brigham and Women's Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2019 Category: Research Source Type: clinical trials